UK Supreme Court Affirms that Claim Scope Must be Commensurate with the Technical Contribution
Regeneron Pharmaceuticals Inc (Respondent) v Kymab Ltd (Appellant)  UKSC 27 Date of judgment: 24 June 2020
German court decision sets back UPC start
Last Friday, the German Federal Constitutional Court issued its long-awaited decision on the validity of the ratification of the UPC by Germany. In their decision, the court rejected the ratification of the UPC because the necessary majority of...
Steep increase in UK R&D funding
In today’s UK Budget the Chancellor, Rishi Sunak, has announced the largest ever increase in Research and Development funding. £22 billion of public money will be invested in R&D, in addition to existing private investment.
UK Intellectual Property Office Indicates Non-Business Days May Count for Future Patent Renewals
In most systems, when a legal deadline falls at the weekend or on some other non-working day it is automatically extended to the next working day.
Court of Justice of the EU issues judgment in Sky v Skykick
In a long-awaited decision, the Court has held that trade mark registrations: - may not be declared invalid on the basis that they include “imprecise” terms such as “computer software” within their specifications; ...
MADAMECOCO, but not CHANEL
Last Friday, the German Federal Constitutional Court issued its long-awaited decision on the validity of the ratification of the UPC by Germany.
Changes to the Guidelines for Examination at the European Patent Office
The European Patent Office Guidelines are updated annually. The latest update came into force on 1 November 2019, and contains significant changes in relation to how the EPO examines inventions relating to artificial intelligence...
UK Supreme Court decision regarding inventor compensation – “outstanding” result for disgruntled employees? Shanks v Unilever Plc
The UK Supreme Court[i] yesterday handed down its decision to award £2M to the inventor of a glucose testing kit, finding that the patent covering the technology was of “outstanding benefit” to his employer.